View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EVS Q1 2025 business update

EVS Q1 2025 business update EVS Q1 2025 business update Despite increasing economic uncertainty, EVS remains cautiously optimistic for 2025 Liège, Belgium | May 16, 2025 We begin the year 2025 reporting a first quarter slightly below our expectations, primarily due to the deferral of certain customer deliveries from March to April. This timing-related impact does not alter the underlying business momentum. Customer demand remains robust across all regions, providing continued confidence in our full-year guidance. We remain cautiously optimistic about achieving our 2025 revenue object...

 PRESS RELEASE

Point sur résultats de l’activité du 1er trimestre 2025 d’EVS

Point sur résultats de l’activité du 1er trimestre 2025 d’EVS Point sur résultats de l’activité du 1er trimestre 2025 d’EVS Malgré l'incertitude économique croissante, EVS reste prudemment optimiste pour 2025 Liège, Belgique | Le 16 mai 2025 Nous commençons l'année 2025 avec un premier trimestre légèrement inférieur à nos attentes, principalement en raison du report de certaines livraisons aux clients de mars à avril. Cet impact lié au calendrier ne modifie pas la dynamique commerciale sous-jacente. La demande des clients reste robuste dans toutes les régions, ce qui renforce la conf...

Argen X SE: 1 director

A director at Argen X SE bought 462 shares at 479.000EUR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Smartphoto Group NV: 1 director

A director at Smartphoto Group NV bought 140,000 shares at 28.500EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

 PRESS RELEASE

Publication of a Transparency Notification

Publication of a Transparency Notification PUBLICATION OF A TRANSPARENCY NOTIFICATION (Article 14, first paragraph of the Law of 2 May 2007 on disclosure of major holdings) On May 9, 2025 EVS Broadcast Equipment has received a transparency notification indicating that Ennismore Fund Management Limited now holds 2.95% of the voting rights of the company. Ennismore Fund Management Limited has therefore crossed down the threshold of 3%. The notification, dated May 9, 2025, contains the following information: Reason for the notification: acquisition or disposal of voting securities or v...

 PRESS RELEASE

PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE

PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE (Article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) EVS Broadcast Equipment a reçu ce 9 mai 2025 une notification de transparence dont il résulte que Ennismore Fund Management Limited détient désormais 2,95% des droits de vote de la société. Ennismore Fund Management Limited a ainsi franchi le seuil de participation de 3% à la baisse. La déclaration, datée du 9 mai 2025, comprend les informations suivantes : Motif de la n...

Wim Hoste
  • Wim Hoste

Tessenderlo FIRST LOOK: Creating a global leader in gelatin/collagen w...

Tessenderlo and Darling Ingredients announced the intention to combine their gelatin & collagen businesses in a joint venture, in which Tessenderlo would have a 15% stake. In light of the difficult market conditions, we welcome the combination which will lead to a gelatin & collagen powerhouse with a global market share of 35-40%. We still appreciate Tessenderlo for the sizeable free cash flow generation and maintain our Accumulate rating for now.

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Lynn Hautekeete
  • Michiel Declercq
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : AED BB, BPOST BB, COFB BB, MONT BB, ONTEX BB, PROX BB,...

: AED BB, BPOST BB, COFB BB, MONT BB, ONTEX BB, PROX BB, UCB BB, VGP BB, AUTL US, ECMPA NA

Wim Hoste
  • Wim Hoste

Ontex US key to the growth but limited visibility – target price lower...

Ontex is a mix of two tales, ie a mature European business which is a private label market leader in most of its activities whilst its US activities have growth potential on the back of its challenger status and much lower private label penetration. A weak start of the year, intensified competition from A-label brands and limited visibility on the mid term upside from the US business prompt us to become a bit more cautious and lower our target price from € 12 to € 10. Given the significant upsid...

Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures
Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures
Hilde Van Boxstael ... (+6)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Michiel Declercq
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, ARGX BB, ATEB BB, CPINV BB, SOLB BB, CTPNV NA,...

: ABI BB, ARGX BB, ATEB BB, CPINV BB, SOLB BB, CTPNV NA, ZEAL DC, JDEP NA, MRUS US

Thomas Vranken
  • Thomas Vranken

argenx FIRST LOOK: 1Q25 results confirm CIDP momentum

argenx reported a strong quarter with Vyvgart sales coming in at $ 790m, in line with CSS, showcasing the robustness of the commercial engine. We note that the company again reached operating profitability for the quarter. Pipeline timelines are reiterated and we look ahead to the upcoming readout in seronegative gMG (2H25), as well as PoC results in lupus nephritis (Vyvgart, 4Q25), delayed graft function (empa, 2H25) and congenital myasthenic syndrome (‘119, 2H25). Accumulate/ € 670 TP reiterat...

 PRESS RELEASE

argenx Reports First Quarter 2025 Financial Results and Provides Busin...

argenx Reports First Quarter 2025 Financial Results and Provides Business Update $790 million in first quarter global product net sales First patients treated with VYVGART Hytrulo pre-filled syringe for self-injection in US and Germany CIDP global expansion with positive CHMP opinion for VYVGART-SC (vial and pre-filled syringe) in EU Management to host conference call today at 2:30 PM CET (8:30 AM ET) May 8, 2025, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe...

Guy Sips ... (+6)
  • Guy Sips
  • Kristof Samoy
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi

Morning Notes : AALB NA, AD NA, ARCAD NA, SMAR BB, WKL NA, AZE BB, CTP...

: AALB NA, AD NA, ARCAD NA, SMAR BB, WKL NA, AZE BB, CTPNV NA, IMCD NA

 PRESS RELEASE

argenx to Present at BofA Securities 2025 Health Care Conference

argenx to Present at BofA Securities 2025 Health Care Conference May 6, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, and members of the management team will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. PT. A live webcast of the presentation may be accessed on the Investors section of the argenx website at . A replay of the webcast will be...

 PRESS RELEASE

Ontex’s annual shareholders’ meeting: All resolutions approved by a la...

Ontex’s annual shareholders’ meeting: All resolutions approved by a large majority Regulated information Aalst, Belgium, May 5, 2025 – Ontex Group NV, a leading international developer and producer of personal care products, held its annual shareholders’ meeting today. All proposed resolutions were approved by the shareholders with a large majority of votes cast.  The minutes of the annual shareholders’ meeting are available on Ontex’s website at: . Enquiries Investors       Geoffroy Raskin                  Media             Catherine Weyne               About Ontex Ontex is a lea...

 PRESS RELEASE

Jaarlijkse algemene vergadering Ontex: Alle resoluties met grote meerd...

Jaarlijkse algemene vergadering Ontex: Alle resoluties met grote meerderheid goedgekeurd Gereglementeerde informatie Aalst, België, 5 mei 2025 – Ontex Group NV, een toonaangevende internationale ontwikkelaar en producent van persoonlijke verzorgingsproducten, hield vandaag zijn algemene vergadering. Alle voorgestelde resoluties werden door de aandeelhouders goedgekeurd met een grote meerderheid van de uitgebrachte stemmen. De notulen van de jaarlijkse aandeelhoudersvergadering zijn beschikbaar op de website van Ontex: . Inlichtingen Investeerders    Geoffroy Raskin               Media ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch